{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T05:49:00Z","timestamp":1669355340417},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T00:00:00Z","timestamp":1411084800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s10096-014-2245-1","type":"journal-article","created":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T19:07:45Z","timestamp":1414696065000},"page":"385-393","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association between IL7RA polymorphisms and the successful therapy against HCV in HIV\/HCV-coinfected patients"],"prefix":"10.1007","volume":"34","author":[{"given":"M.","family":"Guzm\u00e1n-Fulgencio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Berenguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Pineda-Tenor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Jim\u00e9nez-Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Garc\u00eda-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Ald\u00e1miz-Echevarria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Carrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Diez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Tejerina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Briz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Resino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,19]]},"reference":[{"issue":"Suppl 1","key":"2245_CR1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/liv.12082","volume":"33","author":"MS Sulkowski","year":"2013","unstructured":"Sulkowski MS (2013) HCV therapy in HIV-infected patients. Liver Int 33(Suppl 1):63\u201367","journal-title":"Liver Int"},{"issue":"1","key":"2245_CR2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00002030-200401020-00008","volume":"18","author":"L Moreno","year":"2004","unstructured":"Moreno L, Quereda C, Moreno A, Perez-El\u00edas MJ, Antela A, Casado JL, Dronda F, Mateos ML, B\u00e1rcena R, Moreno S (2004) Pegylated interferon alpha2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients. AIDS 18(1):67\u201373","journal-title":"AIDS"},{"issue":"13","key":"2245_CR3","doi-asserted-by":"crossref","first-page":"F27","DOI":"10.1097\/00002030-200409030-00003","volume":"18","author":"M Laguno","year":"2004","unstructured":"Laguno M, Murillas J, Blanco JL, Mart\u00ednez E, Miquel R, S\u00e1nchez-Tapias JM, Bargallo X, Garc\u00eda-Criado A, de Lazzari E, Larrousse M, Le\u00f3n A, Lonc\u00e1 M, Milinkovic A, Gatell JM, Mallolas J (2004) Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV\/HCV co-infected patients. AIDS 18(13):F27\u2013F36","journal-title":"AIDS"},{"key":"2245_CR4","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/1741-7015-11-234","volume":"11","author":"JK Rockstroh","year":"2013","unstructured":"Rockstroh JK, Bhagani S (2013) Managing HIV\/hepatitis C co-infection in the era of direct acting antivirals. BMC Med 11:234","journal-title":"BMC Med"},{"issue":"6","key":"2245_CR5","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.chom.2013.05.014","volume":"13","author":"CT Ng","year":"2013","unstructured":"Ng CT, Snell LM, Brooks DG, Oldstone MB (2013) Networking at the level of host immunity: immune cell interactions during persistent viral infections. Cell Host Microbe 13(6):652\u2013664","journal-title":"Cell Host Microbe"},{"issue":"4","key":"2245_CR6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cell.2011.01.011","volume":"144","author":"M Pellegrini","year":"2011","unstructured":"Pellegrini M, Calzascia T, Toe JG, Preston SP, Lin AE, Elford AR, Shahinian A, Lang PA, Lang KS, Morre M, Assouline B, Lahl K, Sparwasser T, Tedder TF, Paik JH, DePinho RA, Basta S, Ohashi PS, Mak TW (2011) IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology. Cell 144(4):601\u2013613","journal-title":"Cell"},{"issue":"2","key":"2245_CR7","doi-asserted-by":"crossref","first-page":"621","DOI":"10.4049\/jimmunol.1201970","volume":"190","author":"L Hou","year":"2013","unstructured":"Hou L, Jie Z, Desai M, Liang Y, Soong L, Wang T, Sun J (2013) Early IL-17 production by intrahepatic T cells is important for adaptive immune responses in viral hepatitis. J Immunol 190(2):621\u2013629","journal-title":"J Immunol"},{"issue":"8","key":"2245_CR8","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1128\/JVI.03122-12","volume":"87","author":"EC Shin","year":"2013","unstructured":"Shin EC, Park SH, Nascimbeni M, Major M, Caggiari L, de Re V, Feinstone SM, Rice CM, Rehermann B (2013) The frequency of CD127(+) hepatitis C virus (HCV)-specific T cells but not the expression of exhaustion markers predicts the outcome of acute HCV infection. J Virol 87(8):4772\u20134777","journal-title":"J Virol"},{"issue":"2","key":"2245_CR9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2893.2012.01618.x","volume":"20","author":"JR Larrubia","year":"2013","unstructured":"Larrubia JR, Lokhande MU, Garc\u00eda-Garz\u00f3n S, Miquel J, Gonz\u00e1lez-Praetorius A, Parra-Cid T, Sanz-de-Villalobos E (2013) Persistent hepatitis C virus (HCV) infection impairs HCV-specific cytotoxic T cell reactivity through Mcl-1\/Bim imbalance due to CD127 down-regulation. J Viral Hepat 20(2):85\u201394","journal-title":"J Viral Hepat"},{"issue":"5141","key":"2245_CR10","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1126\/science.8266077","volume":"262","author":"M Noguchi","year":"1993","unstructured":"Noguchi M, Nakamura Y, Russell SM, Ziegler SF, Tsang M, Cao X, Leonard WJ (1993) Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. Science 262(5141):1877\u20131880","journal-title":"Science"},{"issue":"10","key":"2245_CR11","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1097\/QAD.0b013e3283606c2d","volume":"27","author":"HJ Hartling","year":"2013","unstructured":"Hartling HJ, Th\u00f8rner LW, Erikstrup C, Zinyama R, Kallestrup P, Gomo E, Nielsen SD, Ullum H (2013) Polymorphisms in the interleukin-7 receptor \u03b1 gene and mortality in untreated HIV-infected individuals. AIDS 27(10):1615\u20131620","journal-title":"AIDS"},{"issue":"2","key":"2245_CR12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/157016212799937209","volume":"10","author":"S Limou","year":"2012","unstructured":"Limou S, Melica G, Coulonges C, Leli\u00e8vre JD, Do H, McGinn S, Gut IG, L\u00e9vy Y, Zagury JF (2012) Identification of IL7RA risk alleles for rapid progression during HIV-1 infection: a comprehensive study in the GRIV cohort. Curr HIV Res 10(2):143\u2013150","journal-title":"Curr HIV Res"},{"issue":"1","key":"2245_CR13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/gene.2011.65","volume":"13","author":"R Rajasuriar","year":"2012","unstructured":"Rajasuriar R, Booth DR, Gouillou M, Spelman T, James I, Solomon A, Chua K, Stewart G, Deeks S, Bangsberg DR, Muzoora C, Cameron PU, Hunt P, Martin J, Lewin SR (2012) The role of SNPs in the \u03b1-chain of the IL-7R gene in CD4+ T-cell recovery in HIV-infected African patients receiving suppressive cART. Genes Immun 13(1):83\u201393","journal-title":"Genes Immun"},{"issue":"1","key":"2245_CR14","first-page":"31.e1","volume":"28","author":"Panel de expertos de Gesida, Secretar\u00eda del Plan Nacional sobre el Sida (SPNS) y Asociaci\u00f3n Espa\u00f1ola para el Estudio del H\u00edgado (AEEH)","year":"2010","unstructured":"Panel de expertos de Gesida, Secretar\u00eda del Plan Nacional sobre el Sida (SPNS) y Asociaci\u00f3n Espa\u00f1ola para el Estudio del H\u00edgado (AEEH) (2010) Recommendations of Gesida\/PNS\/AEEH for the management and treatment of the adult patient co-infected with HIV and hepatitis A, B and C virus. Enferm Infecc Microbiol Clin 28(1):31.e1\u201331.e31","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"4","key":"2245_CR15","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.eimc.2008.11.002","volume":"27","author":"Panel de expertos de Gesida y Plan Nacional sobre el Sida","year":"2009","unstructured":"Panel de expertos de Gesida y Plan Nacional sobre el Sida (2009) Recommendations from the GESIDA\/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009). Enferm Infecc Microbiol Clin 27(4):222\u2013235","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"7","key":"2245_CR16","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/aje\/155.7.645","volume":"155","author":"LE Thorpe","year":"2002","unstructured":"Thorpe LE, Ouellet LJ, Hershow R, Bailey SL, Williams IT, Williamson J, Monterroso ER, Garfein RS (2002) Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol 155(7):645\u2013653","journal-title":"Am J Epidemiol"},{"issue":"7","key":"2245_CR17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412\u2013419","journal-title":"Diabetologia"},{"issue":"3","key":"2245_CR18","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/BF01536249","volume":"34","author":"WH Jacobs","year":"1989","unstructured":"Jacobs WH, Goldberg SB (1989) Statement on outpatient percutaneous liver biopsy. Dig Dis Sci 34(3):322\u2013323","journal-title":"Dig Dis Sci"},{"issue":"1","key":"2245_CR19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jinf.2010.11.003","volume":"62","author":"S Resino","year":"2011","unstructured":"Resino S, Seoane JA, Bell\u00f3n JM, Dorado J, Martin-Sanchez F, Alvarez E, Cos\u00edn J, L\u00f3pez JC, Lop\u00e9z G, Miralles P, Berenguer J (2011) An artificial neural network improves the non-invasive diagnosis of significant fibrosis in HIV\/HCV coinfected patients. J Infect 62(1):77\u201386","journal-title":"J Infect"},{"issue":"4","key":"2245_CR20","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","volume":"49","author":"MG Ghany","year":"2009","unstructured":"Ghany MG, Strader DB, Thomas DL, Seeff LB; American Association for the Study of Liver Diseases (2009) Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 49(4):1335\u20131374","journal-title":"Hepatology"},{"issue":"9","key":"2245_CR21","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/QAD.0b013e3281084e4d","volume":"21","author":"V Soriano","year":"2007","unstructured":"Soriano V, Puoti M, Sulkowski M, Cargnel A, Benhamou Y, Peters M, Mauss S, Br\u00e4u N, Hatzakis A, Pol S, Rockstroh J (2007) Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel. AIDS 21(9):1073\u20131089","journal-title":"AIDS"},{"issue":"Web Server issu","key":"2245_CR22","doi-asserted-by":"crossref","first-page":"W76","DOI":"10.1093\/nar\/gks397","volume":"40","author":"YC Cheng","year":"2012","unstructured":"Cheng YC, Hsiao FC, Yeh EC, Lin WJ, Tang CY, Tseng HC, Wu HT, Liu CK, Chen CC, Chen YT, Yao A (2012) VarioWatch: providing large-scale and comprehensive annotations on human genomic variants in the next generation sequencing era. Nucleic Acids Res 40(Web Server issue):W76\u2013W81","journal-title":"Nucleic Acids Res"},{"issue":"1\u20132","key":"2245_CR23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cellimm.2013.11.001","volume":"286","author":"JR Larrubia","year":"2013","unstructured":"Larrubia JR, Lokhande MU, Moreno-Cubero E, Garc\u00eda-Garz\u00f3n S, Miquel J, Parra-Cid T, Gonz\u00e1lez-Praetorious A, Perna C, L\u00e1zaro A, Sanz-de-Villalobos E (2013) HCV-specific CD8+ cell detection at week 12 of chronic hepatitis C treatment with PEG-interferon-\u03b12b\/ribavirin correlates with infection resolution. Cell Immunol 286(1\u20132):31\u201338","journal-title":"Cell Immunol"},{"issue":"9","key":"2245_CR24","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/ng2103","volume":"39","author":"SG Gregory","year":"2007","unstructured":"Gregory SG, Schmidt S, Seth P, Oksenberg JR, Hart J, Prokop A, Caillier SJ, Ban M, Goris A, Barcellos LF, Lincoln R, McCauley JL, Sawcer SJ, Compston DA, Dubois B, Hauser SL, Garcia-Blanco MA, Pericak-Vance MA, Haines JL; Multiple Sclerosis Genetics Group (2007) Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet 39(9):1083\u20131091","journal-title":"Nat Genet"},{"issue":"4","key":"2245_CR25","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/gutjnl-2012-304377","volume":"63","author":"E Larrea","year":"2014","unstructured":"Larrea E, Riezu-Boj JI, Aldabe R, Guembe L, Echeverria I, Balasiddaiah A, Gastaminza P, Civeira MP, Sarobe P, Prieto J (2014) Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytes. Gut 63(4):665\u2013673","journal-title":"Gut"},{"issue":"3","key":"2245_CR26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng1958","volume":"39","author":"J Yamanouchi","year":"2007","unstructured":"Yamanouchi J, Rainbow D, Serra P, Howlett S, Hunter K, Garner VE, Gonzalez-Munoz A, Clark J, Veijola R, Cubbon R, Chen SL, Rosa R, Cumiskey AM, Serreze DV, Gregory S, Rogers J, Lyons PA, Healy B, Smink LJ, Todd JA, Peterson LB, Wicker LS, Santamaria P (2007) Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat Genet 39(3):329\u2013337","journal-title":"Nat Genet"},{"issue":"7","key":"2245_CR27","doi-asserted-by":"crossref","first-page":"e101441","DOI":"10.1371\/journal.pone.0101441","volume":"9","author":"H Kared","year":"2014","unstructured":"Kared H, Saeed S, Klein MB, Shoukry NH (2014) CD127 expression, exhaustion status and antigen specific proliferation predict sustained virologic response to IFN in HCV\/HIV co-infected individuals. PLoS One 9(7):e101441","journal-title":"PLoS One"},{"issue":"2","key":"2245_CR28","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1053\/j.gastro.2012.10.047","volume":"144","author":"B Seigel","year":"2013","unstructured":"Seigel B, Bengsch B, Lohmann V, Bartenschlager R, Blum HE, Thimme R (2013) Factors that determine the antiviral efficacy of HCV-specific CD8(+) T cells ex vivo. Gastroenterology 144(2):426\u2013436","journal-title":"Gastroenterology"},{"issue":"12","key":"2245_CR29","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1084\/jem.20030239","volume":"197","author":"NH Shoukry","year":"2003","unstructured":"Shoukry NH, Grakoui A, Houghton M, Chien DY, Ghrayeb J, Reimann KA, Walker CM (2003) Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. J Exp Med 197(12):1645\u20131655","journal-title":"J Exp Med"},{"issue":"20","key":"2245_CR30","doi-asserted-by":"crossref","first-page":"10017","DOI":"10.1128\/JVI.01083-08","volume":"82","author":"G Badr","year":"2008","unstructured":"Badr G, B\u00e9dard N, Abdel-Hakeem MS, Trautmann L, Willems B, Villeneuve JP, Haddad EK, S\u00e9kaly RP, Bruneau J, Shoukry NH (2008) Early interferon therapy for hepatitis C virus infection rescues polyfunctional, long-lived CD8+ memory T cells. J Virol 82(20):10017\u201310031","journal-title":"J Virol"},{"issue":"7","key":"2245_CR31","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/gene.2012.34","volume":"13","author":"KL Kreft","year":"2012","unstructured":"Kreft KL, Verbraak E, Wierenga-Wolf AF, van Meurs M, Oostra BA, Laman JD, Hintzen RQ (2012) Decreased systemic IL-7 and soluble IL-7R\u03b1 in multiple sclerosis patients. Gene Immun 13(7):587\u2013592","journal-title":"Gene Immun"},{"issue":"4","key":"2245_CR32","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/gene.2009.106","volume":"11","author":"B Broux","year":"2010","unstructured":"Broux B, Hellings N, Venken K, Rummens JL, Hensen K, Van Wijmeersch B, Stinissen P (2010) Haplotype 4 of the multiple sclerosis-associated interleukin-7 receptor alpha gene influences the frequency of recent thymic emigrants. Gene Immun 11(4):326\u2013333","journal-title":"Gene Immun"},{"issue":"12","key":"2245_CR33","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1097\/QAD.0000000000000354","volume":"28","author":"HJ Hartling","year":"2014","unstructured":"Hartling HJ, Th\u00f8rner LW, Erikstrup C, Harritsh\u00f8j LH, Kronborg G, Pedersen C, Larsen CS, Helleberg M, Gerstoft J, Obel N, Ullum H, Nielsen SD (2014) Polymorphism in interleukin-7 receptor \u03b1 gene is associated with faster CD4+ T-cell recovery after initiation of combination antiretroviral therapy. AIDS 28(12):1739\u20131748","journal-title":"AIDS"},{"issue":"5","key":"2245_CR34","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1053\/j.gastro.2014.03.003","volume":"146","author":"JM Pawlotsky","year":"2014","unstructured":"Pawlotsky JM (2014) New hepatitis C therapies: the toolbox, strategies, and challenges. Gastroenterology 146(5):1176\u20131192","journal-title":"Gastroenterology"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-014-2245-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-014-2245-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-014-2245-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T09:35:13Z","timestamp":1559122513000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-014-2245-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,19]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["2245"],"URL":"https:\/\/doi.org\/10.1007\/s10096-014-2245-1","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,19]]}}}